Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Yoshihisa Kuwana is active.

Publication


Featured researches published by Yoshihisa Kuwana.


Biochemical and Biophysical Research Communications | 1987

Expression of chimeric receptor composed of immunoglobulin-derived V regions and T-cell receptor-derived C regions

Yoshihisa Kuwana; Yoshihiro Asakura; Naoko Utsunomiya; Mamoru Nakanishi; Yohji Arata; Seiga Itoh; Fumihiko Nagase; Yoshikazu Kurosawa

Chimeric genes composed of immunoglobulin (Ig)-derived variable (V) regions and T-cell receptor (TCR)-derived constant (C) regions were constructed. The VL and VH genes showing anti-phosphorylcholine (PC) activity were used in this study. Two pairs of chimeric genes, VL-C beta and VH-C alpha genes, and VL-C alpha and VH-C beta genes, were inserted into an expression vector containing both Ecogpt and neo genes, and transfected into EL4 cells. Cells which express both chimeric receptor molecules were established. The activity of the transformants to the antigen was examined by using stopped-flow fluorometry. An increase in the concentration of cytoplasmic calcium ion was observed after addition of Staphylococcus pneumoniae R36A bacteria grown in the choline-containing medium which express PC molecules, but not after the PC-negative bacteria grown in the ethanolamine-containing medium.


Cancer Immunology, Immunotherapy | 1993

A mouse/human chimeric anti-(ganglioside GD3) antibody with enhanced antitumor activities

Kenya Shitara; Yoshihisa Kuwana; Kazuyasu Nakamura; Yuko Tokutake; So Ohta; Hiromasa Miyaji; Mamoru Hasegawa; Nobuo Hanai

Ganglioside GD3, which is one of the major gangliosides expressed on the cell surface of human tumors of neuroectodermal origin has been focused on as a target molecule for passive immunotherapy. We have cloned the cDNA encoding the immunoglobulin light and heavy chains of an anti-GD3 monoclonal antibody KM641 (murine IgG3, κ), and constructed the chimeric genes by linking the cDNA fragments of the murine light and heavy variable regions to cDNA fragments of the human κ and γ1 constant regions, respectively. The transfer of these cDNA constructs into SP2/0 mouse myeloma cells resulted in the production of the chimeric antibody, designated KM871, that retained specific binding activity to GD3. Indirect immunofluorescence revealed the same staining pattern for chimeric KM871 and the mouse counterpart KM641 on GD3-expressing melanoma cells. When human serum and human peripheral blood mononuclear cells were used as effectors in complement-mediated cytotoxicity and antibody-dependent cell-mediated cytotoxicity respectively, the chimeric KM871 was more effective in killing GD3-expressing tumor cells than was the mouse counterpart KM641. Intravenous injection of chimeric KM871 markedly suppressed tumor growth in nude mice. The chimeric KM871, having enhanced antitumor activities and less immunogenicity than the mouse counterpart, would be a useful agent for passive immunotherapy of human cancer.


Brain Research | 2002

Distribution of adenosine A2A receptor antagonist KW-6002 and its effect on gene expression in the rat brain

Shiro Aoyama; Kumiko Koga; Akihisa Mori; Hiromasa Miyaji; Susumu Sekine; Hiroshi Kase; Tatsuo Uchimura; Hiroyuki Kobayashi; Yoshihisa Kuwana

Abstract A novel adenosine A2A receptor selective antagonist, KW-6002 [(E)-1,3-diethyl-8-(3,4-dimethoxystyryl)-7-methyl-3,7-dihydro-1H-purine-2,6-dione], possesses antiparkinsonian activities in rodent and primate models. In the present study, we investigated the distribution of [14C]KW-6002 in forebrain after oral administration at pharmacologically effective doses. Also, we monitored the effects of the compound on preproenkephalin (PPE) and preprotachykinin (PPT) gene expression in rat striatum. The highest level of radioactivity was observed in the striatum after oral administration of [14C]KW-6002; 30 min after 0.1 and 0.3 mg/kg, the density values in the striatum were 2.45 and 2.43 times higher than those in a reference region (frontal cortex), respectively. At the dose of 3 mg/kg, p.o., the ratio was only 1.58 and the compound was distributed more extensively in the brain. The distribution pattern and intensity of radioactivity were maintained even 90 min after the administration of [14C]KW-6002. Oral administration of KW-6002 (0.3 and 3 mg/kg/day) to rats for 14 days reversed the increased gene expression of PPE in striatum that had been depleted of dopamine by prior treatment with 6-hydroxydopamine (6-OHDA). On the other hand, KW-6002 did not alter the decreased gene expression of PPT in 6-OHDA-treated rats. These results are the first to show directly that orally administered KW-6002 is distributed selectively to the striatum and that it modulates the activity of striatopallidal enkephalin-containing neurons but not striatonigral substance P-containing neurons.


FEBS Letters | 1987

Production of the constant domain of murine T-cell receptor β-chain in Escherichia coli

Yoshihisa Kuwana; Seiga Itoh; Fumihiko Nagase; Izumi Nakashima; Yoshikazu Kurosawa

T‐cell antigen receptor is a heterodimer of disulfide‐linked α‐ and β‐chains. Although the essential features of T‐cell receptor seem to be rather similar to those of immunoglobulin, the amount of T‐cell receptor expressed on the surface of a T‐cell is not large enough to be analyzed physico‐chemically. In this study, the DNA fragment encoding 120 amino acids from the 116th to the 235th of the murine, β‐chain which corresponds to the presumed constant domain was inserted into an expression vector in E. coli. A large amount of this 18 kDa protein was observed to be synthesized in E. coli, and might be a good source for the three dimensional analysis of the T‐cell receptor molecule.


Proceedings of the National Academy of Sciences of the United States of America | 1985

Cloning and expression of cDNA for salmon growth hormone in Escherichia coli

Susumu Sekine; Tamio Mizukami; Tatsunari Nishi; Yoshihisa Kuwana; Akiko Saito; Moriyuki Sato; Seiga Itoh; Hiroshi Kawauchi


Archive | 1995

Process for producing humanized chimera antibody

Kenya Shitara; Nobuo Hanai; Mamoru Hasegawa; Hiromasa Miyaji; Yoshihisa Kuwana


International Immunology | 1990

Perforin, a pore-forming protein detectable by monoclonal antibodies, is a functional marker for killer cells

Akemi Kawasaki; Yoichi Shinkai; Yoshihisa Kuwana; Akiko Furuya; Yutaka Iigo; Nobuo Hanai; Seiga Itoh; Hideo Yagita; Ko Okumura


Cancer Research | 1994

Chimeric Anti-Ganglioside GM2 Antibody with Antitumor Activity

Kazuyasu Nakamura; Masamichi Koike; Kenya Shitara; Yoshihisa Kuwana; Kazumi Kiuragi; Shinobu Igarashi; Mamoru Hasegawa; Nobuo Hanai


Archive | 1993

Humanized antibodies to ganglioside GM2

Kazuyasu Nakamura; Masamichi Koike; Kenya Shitara; Nobuo Hanai; Yoshihisa Kuwana; Mamoru Hasegawa


Archive | 1999

Human chimeric antibody specific for the ganglioside GD3

Kenya Shitara; Nobuo Hanai; Mamoru Hasegawa; Hiromasa Miyaji; Yoshihisa Kuwana

Collaboration


Dive into the Yoshihisa Kuwana's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Moriyuki Sato

City of Hope National Medical Center

View shared research outputs
Researchain Logo
Decentralizing Knowledge